Expressing the sense of the Congress that the United States Trade Representative should investigate whether any price control program governing the cost of medication in Mexico or Canada violates any trade agreement.

Summary

Expresses the sense of Congress that the United States Trade Representative should investigate whether any price control program governing the cost of medication in Mexico or Canada violates any trade agreement (or otherwise denies benefits to the United States under any trade agreement), or is discriminatory and burdens or restricts U.S. commerce.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 2 May 2001

   Introduced

   Sponsor introductory remarks on measure. (CR E704)

   Source: IntroReferral

2. 3 May 2001

   Introduced

   Referred to the House Committee on Ways and Means.

   Source: IntroReferral

3. 3 May 2001

   Introduced

   Introduced in House

   Source: IntroReferral

4. 3 May 2001

   Introduced

   Introduced in House

   Source: IntroReferral

5. 8 May 2001

   Referred

   Referred to the Subcommittee on Trade.

   Source: Committee

Votes

No vote records are attached yet.

Versions

• Introduced in House · 3 May 2001 · Official file

Documents

3 official files

• Introduced in House (text)

  Introduced in House · EN · 3 May 2001

  ViewDownloadOpen at official source

• Introduced in House (PDF)

  Introduced in House · EN · 3 May 2001

  ViewDownloadOpen at official source

• Introduced in House

  summary · EN · 3 May 2001

  Open at official source

Sponsors

• JOHN DUNCAN · R · Sponsor
• · hswm00 · Standing

Related records

No cross-record relationships stored yet.